REGULATED PRESS RELEASE published on 07/11/2024 at 07:01, 1 year 10 months ago Biophytis obtient l’autorisation IND de la FDA pour démarrer son étude OBA de phase 2 dans l’obésité Biophytis obtient l'autorisation IND de la FDA pour lancer l'étude OBA de phase 2 dans l'obésité avec BIO101 (20-hydroxyecdysone), visant à améliorer la force musculaire. Le professeur Marc-André Cornier dirigera l'étude multicentrique aux Etats-Unis Biophytis BIO101 Obésité Autorisation IND Étude OBA
REGULATED PRESS RELEASE published on 07/11/2024 at 07:01, 1 year 10 months ago Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity Biophytis obtains FDA approval to start phase 2 OBA study in obesity with BIO101 (20-hydroxyecdysone), focusing on muscle strength improvement. Study led by Prof. Marc-André Cornier to start mid-2024 in the USA Biophytis FDA Approval Obesity Treatment BIO101 Phase 2 OBA Study
PRESS RELEASE published on 07/11/2024 at 07:00, 1 year 10 months ago Gerresheimer remains on track in 1st half year 2024 Gerresheimer remains on track with 1.7% revenue growth and 2.9% EBITDA increase in the 1st half of 2024. Plastics & Devices division shows good revenue growth and improved margin. Forecast for 2024 and 2025 confirmed EBITDA Revenue Growth Forecast Gerresheimer 1st Half Year 2024
PRESS RELEASE published on 07/11/2024 at 06:58, 1 year 10 months ago DocMorris with accelerated and significant eRx growth in new customers, market share and revenue DocMorris reports accelerated eRx growth in new customers, market share, and revenue, with significant progress in eRx business and expanding customer base Revenue Market Share DocMorris ERx Growth CardLink
PRESS RELEASE published on 07/11/2024 at 03:00, 1 year 10 months ago Charting the Future of Nutrition: Mission Hill Foods Expands Research and Strengthens Market Presence in North America Mission Hill Foods invests in advanced research, dev, & sustainable practices for consumer health, expanding its capabilities & initiatives in North America North America Research Development Sustainable Practices Mission Hill Foods
PRESS RELEASE published on 07/11/2024 at 01:55, 1 year 10 months ago Organto Provides Bi-Weekly Update on Filing of 2023 Annual Financial Statements and Status of MCTO Organto Foods Inc. provides update on management cease trade order for late filing of annual financial statements. Company and auditors working to complete filings Business Update Management Cease Trade Order Annual Financial Statements Organto Foods Inc. Organic Products
PRESS RELEASE published on 07/11/2024 at 01:19, 1 year 10 months ago Final Bell Holdings International Announces Revocation of Cease Trade Order and Closing of First Tranche of a US$12,000,000 Note Financing Final Bell Holdings International Ltd. lifts cease trade order and closes first tranche of US$12 million convertible notes offering through subsidiary FBI for expansion in the United States Expansion Final Bell Holdings International Ltd. Cease Trade Order Convertible Notes Offering FBI
PRESS RELEASE published on 07/11/2024 at 00:00, 1 year 10 months ago Mission Hill Highlights Advanced Formulations for Modern Health Needs, Focusing on Women's Health Mission Hill Foods introduces premium products targeting gut health, heart health, vision protection, and immune support. Focus on women's health, product quality, sustainability, and innovative research projects Innovation Women's Health Gut Health Mission Hill Foods Premium Products
PRESS RELEASE published on 07/10/2024 at 22:30, 1 year 10 months ago Gladstone Commercial Provides a Semi-Annual Business Update Gladstone Commercial Corporation provides semi-annual update on portfolio performance amid market volatility. Highlights include 100% rent collection, high portfolio occupancy, property acquisitions, and lease extensions Gladstone Commercial Corporation REIT Portfolio Performance Property Acquisitions Rent Collection
PRESS RELEASE published on 07/10/2024 at 22:27, 1 year 10 months ago abrdn U.S. Closed-End Funds Announce Distribution Payment Details abrdn U.S. Closed-End Funds announce distribution payments to shareholders on July 31, 2024, and provide estimated sources of distributions and fiscal year-to-date data Shareholders Abrdn U.S. Closed-End Funds Distribution Payments Fiscal Year Estimated Sources
Published on 05/21/2026 at 01:25, 4 hours 34 minutes ago Mongolia Growth Group Announces Completion of Arrangement and Changes to the Board and Executive Leadership
Published on 05/20/2026 at 22:40, 7 hours 19 minutes ago Jaguar Health Reports First Quarter 2026 Financials
Published on 05/20/2026 at 22:15, 7 hours 44 minutes ago Fox River Resources Corporation Obtains Interim Order for Plan of Arrangement and Provides Details of Special Meeting
Published on 05/20/2026 at 15:28, 14 hours 31 minutes ago Sarama Resources Announces Private Equity Placement of A$1.5m
Published on 05/20/2026 at 15:01, 14 hours 58 minutes ago Kidoz Inc. Appoints Tarrnie Williams Jr. as Chief Operating Officer
Published on 05/20/2026 at 22:00, 7 hours 59 minutes ago Nebius and Bloom Energy partner to power AI infrastructure build-out
Published on 05/20/2026 at 21:35, 8 hours 24 minutes ago IGEL and Zscaler Release Healthcare Security Blueprints for Distributed Care Delivery
Published on 05/20/2026 at 20:15, 9 hours 44 minutes ago EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S expands capacity for AI substrates
Published on 05/20/2026 at 19:34, 10 hours 25 minutes ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Final Results Announcement
Published on 05/20/2026 at 19:34, 10 hours 25 minutes ago EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S intends to issue a (Hybrid) Convertible Bond and/or a Hybrid Bond; no dividend for the financial year 2025/26
Published on 05/20/2026 at 18:00, 11 hours 59 minutes ago General shareholders meeting of 20 May, 2026
Published on 05/20/2026 at 18:00, 11 hours 59 minutes ago General shareholders meeting of 20 May, 2026
Published on 05/20/2026 at 17:45, 12 hours 14 minutes ago Report on share repurchases from 13 to 19 May 2026